Filtered By:
Specialty: Universities & Medical Training
Condition: Thrombosis

This page shows you your search results in order of date. This is page number 11.

Order by Relevance | Date

Total 257 results found since Jan 2013.

Relation of interleukin-6 levels in COVID-19 patients with major adverse cardiac events
Proc (Bayl Univ Med Cent). 2021 Sep 1;35(1):6-9. doi: 10.1080/08998280.2021.1961571. eCollection 2022.ABSTRACTElevated interleukin-6 (IL-6) levels may correlate with disease severity in COVID-19. We analyzed whether there was an association between elevated IL-6 levels and major adverse cardiac events (MACE) and/or mortality in COVID-19 patients. A retrospective chart review was performed on COVID-19 patients among four hospitals in one health system from March to May 2020, extracting information on baseline characteristics, MACE (i.e., myocardial infarction, stroke, deep venous thrombosis/pulmonary embolism, or shock requ...
Source: Baylor University Medical Center Proceedings - December 30, 2021 Category: Universities & Medical Training Authors: Nicholas Nguyen Hao Nguyen Chijioke Ukoha Lawrence Hoang Chirag Patel Farukh G Ikram Priyanka Acharya Anmol Dhillon Manavjot Sidhu Source Type: research

Independent risk factors of atrial thrombosis in patients with nonvalvular atrial fibrillation and low CHA < sub > 2 < /sub > DS < sub > 2 < /sub > -VASc scores
CONCLUSIONS: LAD enlargement, HCM, and an elevated CRP level are independent risk factors for atrial thrombosis in NVAF patients with low CHA2DS2-VASc scores.Active anticoagulation therapy should be administered for these patients once these risk factors are detected to prevent the occurrence of stroke.PMID:34549717 | DOI:10.12122/j.issn.1673-4254.2021.08.17
Source: Journal of Southern Medical University - September 22, 2021 Category: Universities & Medical Training Authors: M Zhou J Chen H Wang S Xi T Gan L Zhao Source Type: research